The global Cell & Gene Therapy Bioanalytical Testing Services Market is poised for substantial growth, with a valuation of USD 503.91 million in 2023 and expected to expand to USD 950.06 million by 2032. This represents a robust Compound Annual Growth Rate (CAGR) of 7.3% from 2024 to 2032, reflecting strong momentum in the biopharmaceutical sector. The rising demand for advanced...